Oligomerization of Mannan-binding Lectin Dictates Binding Properties and Complement Activation

被引:27
|
作者
Kjaer, T. R. [1 ]
Jensen, L. [1 ]
Hansen, A. [1 ]
Dani, R. [2 ]
Jensenius, J. C. [1 ]
Dobo, J. [2 ]
Gal, P. [2 ]
Thiel, S. [1 ]
机构
[1] Aarhus Univ, Dept Biomed, Bartholins Alle 6,Bldg 1242, DK-8000 Aarhus C, Denmark
[2] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary
关键词
PATTERN-RECOGNITION; PATHWAY ACTIVATION; MANNOSE-BINDING; SERINE PROTEASES; MASP-1; COMPLEXES; COLLECTIN; MBL; FICOLIN; PROTEIN;
D O I
10.1111/sji.12441
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The complement system is a part of the innate immune system and is involved in recognition and clearance of pathogens and altered-self structures. The lectin pathway of the complement system is initiated when soluble pattern recognition molecules (PRMs) with collagen-like regions bind to foreign or altered self-surfaces. Associated with the collagen-like stems of these PRMs are three mannan-binding lectin (MBL)-associated serine proteases (MASPs) and two MBL-associated proteins (MAps). The most studied of the PRMs, MBL, is present in serum mainly as trimeric and tetrameric oligomers of the structural subunit. We hypothesized that oligomerization of MBL may influence both the potential to bind to micro organisms and the interaction with the MASPs and MAps, thus influencing the ability to initiate complement activation. When testing binding at 37 degrees C, we found higher binding of tetrameric MBL to Staphylococcus aureus (S. aureus) than trimeric and dimeric MBL. In serum, we found that tetrameric MBL was the main oligomeric form present in complexes with the MASPs and MAp44. Such preference was confirmed using purified forms of recombinant MBL (rMBL) oligomers, where tetrameric rMBL interacted stronger with all of the MASPs and MAp44, compared to trimeric MBL. As a direct consequence of the weaker interaction with the MASPs, we found that trimeric rMBL was inferior to tetrameric rMBL in activating the complement system. Our data suggest that the oligomeric state of MBL is crucial both for the binding properties and the effector function of MBL.
引用
收藏
页码:12 / 19
页数:8
相关论文
共 50 条
  • [1] An assay for the mannan-binding lectin pathway of complement activation
    Petersen, SV
    Thiel, S
    Jensen, L
    Steffensen, R
    Jensenius, JC
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 257 (1-2) : 107 - 116
  • [2] An assay for measuring the mannan-binding lectin pathway of complement activation in chickens
    Norupi, L. R.
    Juul-Madsen, H. R.
    [J]. POULTRY SCIENCE, 2007, 86 (11) : 2322 - 2326
  • [3] The mannan-binding lectin pathway of complement activation: biology and disease association
    Petersen, SV
    Thiel, S
    Jensenius, JC
    [J]. MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 133 - 149
  • [4] Assays for the functional activity of the mannan-binding lectin pathway of complement activation
    Thiel, S
    Moller-Kristensen, M
    Jensen, LI
    Jensenius, JC
    [J]. IMMUNOBIOLOGY, 2002, 205 (4-5) : 446 - 454
  • [5] Mannan-Binding Lectin and Activation of Complement in Model of Type 1 Diabetes
    Ostergaard, Jakob A.
    Bjerre, Mette
    Dagnaes-Hansen, Frederik
    Hansen, Iroels K.
    Thiel, Steffen
    Flyvbjerg, Allan
    [J]. DIABETES, 2012, 61 : A143 - A143
  • [6] New perspectives on mannan-binding lectin-mediated complement activation
    Degn, Soren E.
    Thiel, Steffen
    Jensenius, Jens C.
    [J]. IMMUNOBIOLOGY, 2007, 212 (4-5) : 301 - 311
  • [7] MANNAN-BINDING PROTEIN, A COMPLEMENT ACTIVATING ANIMAL LECTIN
    THIEL, S
    [J]. IMMUNOPHARMACOLOGY, 1992, 24 (02): : 91 - 99
  • [8] Requirements for lectin pathway activation by chicken mannan-binding lectin
    Koppenheffer, TL
    [J]. FASEB JOURNAL, 2003, 17 (07): : C110 - C110
  • [9] Mannan-binding lectin in malignancy
    Swierzko, Anna S.
    Kilpatrick, David C.
    Cedzynski, Maciej
    [J]. MOLECULAR IMMUNOLOGY, 2013, 55 (01) : 16 - 21
  • [10] Mannan-binding lectin in neonates
    Szala, A.
    MacDonald, S.
    Domzalska-Popadiuk, I.
    Atkinson, A.
    Cedzynski, M.
    Swierzko, A.
    Szemraj, J.
    Borkowska, M.
    Szczapa, J.
    Matsushita, M.
    Turner, M.
    Kilpatrick, D.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S497 - S498